SCANPHARM A/S: Financial statements 2013
CVR: 16279099
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
SCANPHARM A/S (CVR 16279099) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 20,949,478 and a net result of DKK 399,646. Equity in the 2013 report amounted to DKK 10,557,786. The solvency ratio was 30.6%.
- Gross Profit
- DKK 20,949,478
- Profit/Loss
- DKK 399,646
- Equity
- DKK 10,557,786
- Total Assets
- DKK 34,489,519
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
SCANPHARM A/S has published its annual report for 2012.
About SCANPHARM A/S
SCANPHARM A/S is a Danish company of the type Aktieselskab based in Birkerød, founded in 1992. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named SCANPHARM A/S AF 1992 and A/S SCANPHARM AF 1992. The management consists of Andreas Bjørn Jensen. The board consists of Janus Doré Pagh (chair), Andreas Bjørn Jensen and Hanne Bjørn Jensen. The company is owned by CHLOPETHAN A/S and Peluli Holding ApS. The company has 51 employees (2018). In 2025, the company reported a gross profit of DKK 29,716,677 and a net result of DKK 962,722 compared with DKK 582,684 the year before. Equity in the 2025 report amounted to DKK 3,045,406.